Drug Drug interaction studies in preclinical stage, reduces unexpected adverse events rate in clinical trails
Specialized manufacturer of in vitro kits to evaluate uptake transporters, OCT2 and MATE1.
The evaluation of drug interactions in preclinical stages optimizes novel drug development
Specialized manufacturer of in vitro kits indicated to evaluate pharmacological relevant efflux and uptake receptors for TDI assays.
The latest FDA guidance on in vitro drug-drug interactions is finally out!
Among other things, the agency explains that DDIs are a critical factor in a drug’s overall benefit-risk profile.
